Home/Filings/8-K/0000031791-26-000003
8-K//Current report

REVVITY, INC. 8-K

Accession 0000031791-26-000003

$RVTYCIK 0000031791operating

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 9:14 AM ET

Size

3.3 MB

Accession

0000031791-26-000003

Research Summary

AI-generated summary of this filing

Updated

Revvity, Inc. Reports Preliminary Q4 2025 Results; JPM Conference Presentation

What Happened

  • Revvity, Inc. (RVTY) announced preliminary expectations for its financial results for the fourth quarter ended December 28, 2025 and said it will release full fourth-quarter and full-year 2025 results on February 2, 2026.
  • The company furnished a press release (Exhibit 99.1) dated January 12, 2026 regarding the update and also furnished presentation materials (Exhibit 99.2) for a presentation by President and CEO Prahlad Singh at the 44th Annual J.P. Morgan Healthcare Conference.

Key Details

  • Quarter covered: Q4 ended December 28, 2025.
  • Earnings release and related call scheduled for: February 2, 2026.
  • CEO presenting: Prahlad Singh at the 44th Annual J.P. Morgan Healthcare Conference (presentation materials furnished as Exhibit 99.2).
  • Press release providing the update was issued January 12, 2026 and furnished as Exhibit 99.1 to the 8-K.

Why It Matters

  • Investors should watch the February 2, 2026 earnings release for the company’s final Q4 and full-year 2025 results and any details on revenue, earnings, or outlook that could affect the stock.
  • The JP Morgan presentation is an additional forum where management may discuss business performance and strategy; the presentation materials are included with the 8-K for review. Note that the exhibits were furnished with the Form 8-K (not “filed” for certain SEC liabilities).

Issuer

REVVITY, INC.

CIK 0000031791

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000031791

Filing Metadata

Form type
8-K
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 9:14 AM ET
Size
3.3 MB